vTv Therapeutics Inc. (VTVT) , a stock from Biotechnology Industry, has a value of $1.19 per share, noted a price change of 43.25% in recent trade close. The price to sales ratio is 137.29. The lower price P/S ratio indicates attractive the investment. A low P/S can also be effective in valuing growth stocks that have suffered a temporary setback. A low P/S ratio may indicate possible undervaluation, while a ratio that is significantly above the average may suggest overvaluation. Abbreviated as the P/S ratio or PSR, this ratio is also known as a “sales multiple” or “revenue multiple.”
The company is estimating to achieve earnings per share (EPS) growth of 38.00% in this year and the earnings per share (EPS) growth expected to be 0.80% in the next year.
Analysts mean Recommendation on a stock is noted at 1.70. Analyst Recommendation is an outlook of a stock-market analyst on a stock. Rating Scale: 1.0 represent “Strong Buy” and 2.0 signify “Buy” 3.0 while shows “Hold”. 4.0 display “Sell” and 5.0 reveal “Strong Sell” rating.
The performance for week is 66.57% and the performance for quarter is at -80.56%. The performance for month is -78.28% and the performance for half year is -84.68%. Its monthly volatility value of 17.00% and volatility for the week is valued at 32.35%. The performance for Year to Date (YTD) is -80.20%.
38.70% shares of the company possessed by Institutional Investors. The net percent change held by Institutional Investors has seen a change of -0.67% in last three month period. Insiders own 1.00% of vTv Therapeutics Inc. (VTVT) shares. During last six month record, the net percent change kept by insiders has observed a change of 23.12%.
Indicating how profitable this stock is relative to its assets, the ROA value is observed at -47.50%. The ROA tells us exactly what earnings were generated from the invested capital. A ROI of 34.70% for the company evaluates and compares the efficiency of the various numbers of investments relative to the cost of investments.